Hunan Hansen Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 621.173 million compared to CNY 661.846 million a year ago. Operating income was CNY 122.783 million compared to CNY 100.526 million a year ago. Net income was CNY 103.306 million compared to CNY 86.361 million a year ago. Basic earnings per share from continuing operations was CNY 0.2053 compared to CNY 0.1716 a year ago.